Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Infection|August 8, 2025
Herpes zoster recurrence, and safety and immunogenicity of the recombinant zoster vaccine in adults aged ≥50 years with a history of herpes zoster: A phase 3, randomized controlled trialBisi Jegede, Yingjun Zhou, Helen Hawksworth, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2026
Reduced neutralising antibody responses against emerging 2025/26 influenza A(H1N1)pdm09 subclade D.3.1 and A(H3N2) subclade K viruses among healthcare workers, Finland, August to October 2025Niina Ikonen, Anu Haveri, Erika Lindh, et al.New Microbes and New Infections|November 25, 2024
Convalescent plasma therapy for COVID-19 - Donor selection strategies and establishment of a plasma bankMikael Kajova, Tamim Khawaja, Iris Levonen, et al.Human Vaccines & Immunotherapeutics|March 2, 2026
Randomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-Mat in high-risk pregnant women and their infantsZourab Bebia, Ilse Dieussaert, Lisa Jose, et al.Vaccine|October 29, 2025
Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1Arttu Reinholm, Hira Khan, Terhi Laakso, et al.Scientific Reports|November 4, 2023
High-volume evacuation mitigates viral aerosol spread in dental proceduresRasmus Malmgren, Hanna Välimaa, Lotta Oksanen, et al.Nature Communications|June 29, 2021
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variantsPinja Jalkanen, Pekka Kolehmainen, Hanni K Häkkinen, et al.Pageof 2